Back to News
Market Impact: 0.2
Nutriband Seeks New Patent Protection For AVERSA Transdermal Technology
Source: Nasdaq
Patents & Intellectual PropertyHealthcare & BiotechCompany Fundamentals
Nutriband filed a non-provisional utility patent application with the USPTO to strengthen intellectual property protection for its AVERSA abuse-deterrent transdermal technology. The article provides no financial figures or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
NTRB0.40
More News
- The world needs Ukraine’s grain. Its farmers are running out of reasons to plant
- Why is the Chinese stock market missing the AI rally
- Tesla drops 'Full Self-Driving' brand name in Europe after regulator pushback
- Why is T-Mobile stock tumbling today?
- SpaceX makes big move into wireless. These once 'obsolete' tech stocks could benefit
- Wall Street Week | Michigan Manufacturing, AI Debt Investments, Baby Bonds, Canadian Coal Fight